{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:23:15Z","timestamp":1788877395526,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.vaccine.2010.08.042","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:38:18Z","timestamp":1282466298000},"page":"130-140","source":"Crossref","is-referenced-by-count":11,"title":["Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity"],"prefix":"10.1016","volume":"29","author":[{"given":"Celestine N.","family":"Wanjalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Faul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Gomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.042_bib0005","unstructured":"UNAIDS. 2008 Report on the global AIDS epidemic; 2008."},{"issue":"4 (August)","key":"10.1016\/j.vaccine.2010.08.042_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2010.08.042_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-199901000-00004","article-title":"Poliomyelitis as a paradigm for investment in and success of vaccination programs","volume":"18","author":"Ogra","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/345957","article-title":"Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals","volume":"187","author":"Barron","year":"2003","journal-title":"J Infect Dis"},{"issue":"10 (November)","key":"10.1016\/j.vaccine.2010.08.042_bib0025","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood.V98.10.3016","article-title":"Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection","volume":"98","author":"Pacanowski","year":"2001","journal-title":"Blood"},{"issue":"4 (August)","key":"10.1016\/j.vaccine.2010.08.042_bib0030","first-page":"353","article-title":"Treating HIV-1 infection with dendritic cells","volume":"9","author":"Connolly","year":"2007","journal-title":"Curr Opin Mol Ther"},{"issue":"6673 (March)","key":"10.1016\/j.vaccine.2010.08.042_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"S1 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0040","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/eji.200737400","article-title":"Dendritic cells: understanding immunogenicity","volume":"37","author":"Steinman","year":"2007","journal-title":"Eur J Immunol"},{"issue":"12 (June)","key":"10.1016\/j.vaccine.2010.08.042_bib0045","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI0215962","article-title":"Exploiting dendritic cells to improve vaccine efficacy","volume":"109","author":"Steinman","year":"2002","journal-title":"J Clin Invest"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2010.08.042_bib0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2796.2006.01738.x","article-title":"A dendritic cell-based vaccine for treating HIV infection: background and preliminary results","volume":"261","author":"Andrieu","year":"2007","journal-title":"J Intern Med"},{"issue":"5 (March)","key":"10.1016\/j.vaccine.2010.08.042_bib0055","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1128\/JVI.75.5.2142-2153.2001","article-title":"Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals","volume":"75","author":"Engelmayer","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.042_bib0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.imbio.2004.07.001","article-title":"Production of hepatitis B surface antigen-pulsed dendritic cells from immunosuppressed murine hepatitis B virus carrier: evaluation of immunogenicity of antigen-pulsed dendritic cells in vivo","volume":"209","author":"Furukawa","year":"2004","journal-title":"Immunobiology"},{"issue":"2 (Summer)","key":"10.1016\/j.vaccine.2010.08.042_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/vim.2006.19.210","article-title":"Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3","volume":"19","author":"Xiang","year":"2006","journal-title":"Viral Immunol"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm806","article-title":"Therapeutic dendritic-cell vaccine for simian AIDS","volume":"9","author":"Lu","year":"2003","journal-title":"Nat Med"},{"issue":"2 (July)","key":"10.1016\/j.vaccine.2010.08.042_bib0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.20021924","article-title":"Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha","volume":"198","author":"Lapenta","year":"2003","journal-title":"J Exp Med"},{"issue":"1 (July)","key":"10.1016\/j.vaccine.2010.08.042_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1099\/0022-1317-49-1-161","article-title":"The structural proteins of rabies virus and evidence for their synthesis from separate monocistronic RNA species","volume":"49","author":"Coslett","year":"1980","journal-title":"J Gen Virol"},{"issue":"18 (September)","key":"10.1016\/j.vaccine.2010.08.042_bib0085","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J"},{"issue":"14 (July)","key":"10.1016\/j.vaccine.2010.08.042_bib0090","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1073\/pnas.93.14.7310","article-title":"Highly stable expression of a foreign gene from rabies virus vectors","volume":"93","author":"Mebatsion","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"issue":"2 (September)","key":"10.1016\/j.vaccine.2010.08.042_bib0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.virol.2006.05.010","article-title":"Rabies virus glycoprotein as a carrier for anthrax protective antigen","volume":"353","author":"Smith","year":"2006","journal-title":"Virology"},{"issue":"2 (April)","key":"10.1016\/j.vaccine.2010.08.042_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2174\/1570162033485320","article-title":"Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseases","volume":"1","author":"McKenna","year":"2003","journal-title":"Curr HIV Res"},{"issue":"7 (March)","key":"10.1016\/j.vaccine.2010.08.042_bib0110","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.050589197","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"Schnell","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2004.10.018","article-title":"Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach","volume":"331","author":"Tan","year":"2005","journal-title":"Virology"},{"issue":"6 (March)","key":"10.1016\/j.vaccine.2010.08.042_bib0280","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1128\/JVI.01870-09","article-title":"Characterization of a single-cycle rabies virus-based vaccine vector","volume":"84","author":"Gomme","year":"2010","journal-title":"J Virol"},{"issue":"23 (December)","key":"10.1016\/j.vaccine.2010.08.042_bib0125","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1128\/JVI.75.23.11496-11502.2001","article-title":"Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein","volume":"75","author":"Mebatsion","year":"2001","journal-title":"J Virol"},{"issue":"2 (December)","key":"10.1016\/j.vaccine.2010.08.042_bib0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"Faul","year":"2008","journal-title":"Virology"},{"issue":"3 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.vaccine.2007.10.072","article-title":"Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFkappaB signaling pathway","volume":"26","author":"Li","year":"2008","journal-title":"Vaccine"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2010.08.042_bib0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.00221-07","article-title":"Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals","volume":"15","author":"Connolly","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"2 (February)","key":"10.1016\/j.vaccine.2010.08.042_bib0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CVI.00066-08","article-title":"Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection","volume":"16","author":"Whiteside","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"25 (June)","key":"10.1016\/j.vaccine.2010.08.042_bib0150","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1073\/pnas.0403060101","article-title":"Rabies virus nucleoprotein as a carrier for foreign antigens","volume":"101","author":"Koser","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9 (May)","key":"10.1016\/j.vaccine.2010.08.042_bib0155","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/JVI.75.9.4430-4434.2001","article-title":"Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates","volume":"75","author":"McGettigan","year":"2001","journal-title":"J Virol"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.77.1.237-244.2003","article-title":"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"issue":"8 (April)","key":"10.1016\/j.vaccine.2010.08.042_bib0165","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1158\/0008-5472.CAN-08-3386","article-title":"Lineage-specific T-cell responses to cancer mucosa antigen oppose systemic metastases without mucosal inflammatory disease","volume":"69","author":"Snook","year":"2009","journal-title":"Cancer Res"},{"issue":"May","key":"10.1016\/j.vaccine.2010.08.042_bib0170","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0307s25","article-title":"Isolation of dendritic cells","author":"Inaba","year":"2001","journal-title":"Curr Protoc Immunol"},{"issue":"2 (December)","key":"10.1016\/j.vaccine.2010.08.042_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(97)00138-5","article-title":"Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods","volume":"209","author":"Lecoeur","year":"1997","journal-title":"J Immunol Methods"},{"issue":"1 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/JVI.76.1.19-31.2002","article-title":"Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cells","volume":"76","author":"Foley","year":"2002","journal-title":"J Virol"},{"issue":"5 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0952-7915(00)00148-5","article-title":"Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity","volume":"12","author":"Restifo","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"Suppl. 2 (September)","key":"10.1016\/j.vaccine.2010.08.042_bib0190","doi-asserted-by":"crossref","first-page":"B47","DOI":"10.1016\/j.vaccine.2007.06.006","article-title":"Dendritic cells for active immunotherapy: Optimizing design and man in order to develop commercially and clinically viable products","volume":"25","author":"Nicollete","year":"2007","journal-title":"Vaccine"},{"issue":"5 (March)","key":"10.1016\/j.vaccine.2010.08.042_bib0195","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1128\/JVI.80.5.2194-2205.2006","article-title":"Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells","volume":"80","author":"Ahmed","year":"2006","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2010.08.042_bib0285","doi-asserted-by":"crossref","first-page":"e1001016","DOI":"10.1371\/journal.ppat.1001016","article-title":"Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling","volume":"6","author":"Faul","year":"2010","journal-title":"PLoS Pathog"},{"issue":"19 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0205","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1128\/JVI.77.19.10537-10547.2003","article-title":"Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis","volume":"77","author":"Prehaud","year":"2003","journal-title":"J Virol"},{"issue":"2 (December)","key":"10.1016\/j.vaccine.2010.08.042_bib0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2009.10.051","article-title":"Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIV(mac251) challenge","volume":"28","author":"Faul","year":"2009","journal-title":"Vaccine"},{"issue":"2 (January)","key":"10.1016\/j.vaccine.2010.08.042_bib0215","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.virol.2005.09.004","article-title":"Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2","volume":"344","author":"McGettigan","year":"2006","journal-title":"Virology"},{"issue":"20 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0220","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1128\/JVI.77.20.10889-10899.2003","article-title":"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome","volume":"77","author":"McGettigan","year":"2003","journal-title":"J Virol"},{"issue":"18 (September)","key":"10.1016\/j.vaccine.2010.08.042_bib0225","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"J Virol"},{"issue":"7 (April)","key":"10.1016\/j.vaccine.2010.08.042_bib0230","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1086\/512243","article-title":"Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease","volume":"195","author":"McKenna","year":"2007","journal-title":"J Infect Dis"},{"issue":"1 (Spring)","key":"10.1016\/j.vaccine.2010.08.042_bib0235","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/vim.2006.0052","article-title":"Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile","volume":"20","author":"Gruber","year":"2007","journal-title":"Viral Immunol"},{"issue":"8 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0240","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates","volume":"200","author":"Cenna","year":"2009","journal-title":"J Infect Dis"},{"issue":"12 (December)","key":"10.1016\/j.vaccine.2010.08.042_bib0245","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.4049\/jimmunol.163.12.6762","article-title":"Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion","volume":"163","author":"Engelmayer","year":"1999","journal-title":"J Immunol"},{"issue":"6 (September)","key":"10.1016\/j.vaccine.2010.08.042_bib0250","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.186.6.801","article-title":"Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells","volume":"186","author":"Grosjean","year":"1997","journal-title":"J Exp Med"},{"issue":"10 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0255","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.0.CO;2-X","article-title":"Inhibition of dendritic cell maturation by herpes simplex virus","volume":"29","author":"Salio","year":"1999","journal-title":"Eur J Immunol"},{"issue":"22 (November)","key":"10.1016\/j.vaccine.2010.08.042_bib0260","doi-asserted-by":"crossref","first-page":"14411","DOI":"10.1128\/JVI.79.22.14411-14420.2005","article-title":"Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways","volume":"79","author":"Vidy","year":"2005","journal-title":"J Virol"},{"issue":"6 (March)","key":"10.1016\/j.vaccine.2010.08.042_bib0265","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.4049\/jimmunol.170.6.2817","article-title":"Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo","volume":"170","author":"Kleindienst","year":"2003","journal-title":"J Immunol"},{"issue":"43 (October)","key":"10.1016\/j.vaccine.2010.08.042_bib0270","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.1016\/j.vaccine.2009.05.016","article-title":"A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy","volume":"27","author":"Gandhi","year":"2009","journal-title":"Vaccine"},{"issue":"48 (December)","key":"10.1016\/j.vaccine.2010.08.042_bib0275","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.0911742106","article-title":"HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells","volume":"106","author":"Dai","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T20:40:45Z","timestamp":1711744845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0264410X10011874"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}